177Lu-Plerixafor

N/A

Report date: 2025/11/04 16:07:42

Base Information

Drug Name177Lu-Plerixafor

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists

TargetsC-X-C motif chemokine receptor 4

Therapy Area/IndicationsLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPostgraduate Institute Of Medical Education And Research

China Registration ClassN/A

Develop Information

Active CompaniesPostgraduate Institute Of Medical Education And Research

Inactive CompaniesN/A

Active IndicationsLymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A